Subscribe: Biotechnology
Added By: Feedage Forager Feedage Grade A rated
Language: English
announced  biotech  boston  company  ingenol  nasdaq  phyton biotech  phyton  prnewswire  sept prnewswire  sept  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology

Press Releases from PR Newswire about Biotechnology

Published: Sat, 01 Oct 2016 12:02:38 EDT

Last Build Date: Sat, 01 Oct 2016 07:01:00 EDT


Des cadres de la mise au point de médicaments convergent vers Boston à l'occasion de BioPharm America™ 2016

Sat, 01 Oct 2016 07:01:00 EDT

(image) CARLSBAD, Californie et BOSTON, 1 octobre 2016 /PRNewswire/ -- Plus de 800 cadres de l'industrie des sciences de la vie ont participé à BioPharm America™, événement de partenariat des sciences de la vie à Boston au début de septembre. Les entretiens qui...

Media Files:

New Phase 3 Data Show Significant Efficacy Versus Placebo And Superiority Of Guselkumab Versus Humira® In Treatment Of Moderate To Severe Plaque Psoriasis

Sat, 01 Oct 2016 02:00:00 EDT

(image) VIENNA, Oct. 1, 2016 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today findings from the first of three pivotal Phase 3 studies evaluating guselkumab, a subcutaneously administered anti-interleukin (IL)-23 monoclonal antibody in late-stage...

Media Files:

Global drug development executives converge on Boston for BioPharm America™ 2016

Fri, 30 Sep 2016 16:20:00 EDT

(image) CARLSBAD, Calif. and BOSTON, Sept. 30, 2016 /PRNewswire/ -- Over 800 executives from the life science industry attended BioPharm America™ life science partnering event in Boston in early September. The one-to-one partnering meetings that take place propel M&A and deals in...

Media Files:

Analgesic Solutions Announces Presentation of Signature Quantitative Data Surveillance System

Fri, 30 Sep 2016 14:06:00 EDT

(image) NATICK, Mass., Sept. 30, 2016 /PRNewswire/ -- Analgesic Solutions, a specialty consulting and clinical research company focused on the conduct of clinical trials in pain, announced today the presentation of its signature central statistical surveillance tool for the prospective...

Media Files:

Solicitud de patente para un nuevo método de producción para el mebutato de ingenol en Phyton Biotech

Fri, 30 Sep 2016 13:02:00 EDT

(image) -Solicitud de patente que cubre un nuevo método de producción para el mebutato de ingenol en Phyton Biotech publicada por la Organización Mundial de la Propiedad Intelectual (OMPI) AHRENSBURG, Alemania y FORT WORTH, Texas, 30 de septiembre de 2016 /PRNewswire/ --...

Media Files:

Groundbreaking Bioscience Skill Standards Created by National Community College Consortium with Funding from $15 Million U.S. DOL Grant

Fri, 30 Sep 2016 12:22:00 EDT

(image) WINSTON-SALEM, N.C., Sept. 30, 2016 /PRNewswire/ -- A consortium of 12 community colleges from across the country, utilizing a $15 million grant from the U.S. Department of Labor, has just completed a four-year project that created industry-recognized credentialing standards designed...

Media Files:

Marc and Lynne Benioff's $20 million gift to USC supports research and treatment innovations to fight cancer

Fri, 30 Sep 2016 11:35:00 EDT

LOS ANGELES, Sept. 29, 2016 /PRNewswire-USNewswire/ -- USC Trustee Marc Benioff '86 and his wife, Lynne, have given $20 million toward construction of the Lawrence J. Ellison Institute for Transformative Medicine of USC, a new center in Los Angeles that will combine interdisciplinary...

Misonix Features BoneScalpel™ and SonaStar™ Systems at Congress of Neurological Surgeons ("CNS")

Fri, 30 Sep 2016 10:32:00 EDT

(image) FARMINGDALE, N.Y., Sept. 30, 2016 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic...

Media Files:

Mylan Launches Generic Fortamet® Tablets

Fri, 30 Sep 2016 09:50:00 EDT

(image) HERTFORDSHIRE, England and PITTSBURGH, Sept. 30, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Metformin Hydrochloride Extended-release Tablets USP, 500 mg and 1000 mg, a generic version of Watson's Fortamet®. Mylan received final approval...

Media Files:

Ipsen Biopharmaceuticals, Inc. Announces Nine Poster Presentations at the 2016 North American Neuroendocrine Tumor Society (NANETS) Symposium

Fri, 30 Sep 2016 09:05:00 EDT

BASKING RIDGE, N.J., Sept. 30, 2016 /PRNewswire/ -- Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that nine studies have been selected for poster presentations at the annual symposium of the North American Neuroendocrine...

Reinventing Healthcare: Singularity University's Exponential Medicine Returns to San Diego October 8-11

Fri, 30 Sep 2016 09:00:00 EDT

(image) MOFFETT FIELD, Calif., Sept. 30, 2016 /PRNewswire/ -- Singularity University (SU) is bringing together over 500 global leaders in technology and healthcare for its sixth annual Exponential Medicine Conference October 8-11, 2016 at the Hotel del Coronado in San Diego, California. The...

Media Files:

Backed by Science and Proven Results, TCI Is Integrating Nutraceutical and Cosmeceutical Actives for Brands

Fri, 30 Sep 2016 08:40:00 EDT

(image) TAIPEI, Taiwan, Sept. 30, 2016 /PRNewswire/ -- Over the past few years, the demand for health and anti-aging nutraceutical and cosmeceutical products has grown dramatically, due, mainly, to the rise in the elderly population around the world and the increase in health-conscious...

Media Files:

Tocagen to Present Clinical and Preclinical Data at Two Scientific Meetings

Fri, 30 Sep 2016 08:00:00 EDT

(image) SAN DIEGO, Sept. 30, 2016 /PRNewswire/ -- Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced clinical and preclinical data involving Toca 511 & Toca FC for the treatment of recurrent high grade glioma will be presented at the 10th International...

Media Files:

AbbVie's Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation

Fri, 30 Sep 2016 08:00:00 EDT

(image) NORTH CHICAGO, Ill., Sept. 30, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the investigational, pan-genotypic regimen of...

Media Files:

"The Science Behind Logistics" Webinar, Hosted by Cryoport

Fri, 30 Sep 2016 08:00:00 EDT

(image) IRVINE, Calif., Sept. 30, 2016 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company, announced today that Dr. Mark Sawicki, Chief Commercial Officer, is scheduled to present a webinar titled "The Science Behind...

Media Files:

Der Patentantrag von Phyton Biotech für eine neuartige Produktionsmethode von Ingenolmebutat wurde von der Weltorganisation für geistiges Eigentum (WIPO) veröffentlicht

Fri, 30 Sep 2016 07:28:00 EDT

(image) AHRENSBURG, Deutschland und FORT WORTH, Texas, 30. September 2016 /PRNewswire/ -- Phyton Biotech, ein Pionier bei der Fermentation von Pflanzenzellen (PCF®), gab heute bekannt, dass sein internationaler Patentantrag PCT/EP2016/055989 „PRODUCTION OF INGENOL, INGENOL ESTERS...

Media Files:

BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule

Fri, 30 Sep 2016 07:00:00 EDT

(image) RALEIGH, N.C., Sept. 30, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) reported that according to the Substance Abuse and Mental Health Services Administration (SAMHSA), 1,665 clinicians have applied for and were granted waivers to prescribe buprenorphine...

Media Files:

Regeneron Announces Phase 2 Study of Aflibercept Co-Formulated with Rinucumab (anti-PDGFR-beta) Shows No Benefit Over Aflibercept Alone in Neovascular Age-Related Macular Degeneration

Fri, 30 Sep 2016 07:00:00 EDT

(image) TARRYTOWN, N.Y., Sept. 30, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced topline results from the Phase 2 CAPELLA study evaluating aflibercept co-formulated with rinucumab, an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta)...

Media Files:

BD Expands Efforts To Combat Antimicrobial Resistance With New Automated ID/AST System

Fri, 30 Sep 2016 06:59:00 EDT

(image) FRANKLIN LAKES, N.J., Sept. 30, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of...

Media Files:

Une demande de brevet concernant une nouvelle méthode de production du mébutate d'ingénol chez Phyton Biotech est publiée par l'Organisation mondiale de la propriété intellectuelle (OMPI)

Fri, 30 Sep 2016 06:14:00 EDT

(image) AHRENSBURG, Allemagne et FORT WORTH, Texas, 30 septembre 2016 /PRNewswire/ -- Phyton Biotech, le pionnier de la Plant Cell Fermentation (PCF®), a annoncé aujourd'hui que sa demande de brevet international PCT/EP2016/055989 « PRODUCTION OF INGENOL, INGENOL...

Media Files: